Michel Mélac

Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5–grass pollen tablet for seasonal allergic rhinitis

A. Didier, Hans‐Jørgen Malling, Margitta Worm et al. · Journal of Allergy and Clinical Immunology · 2007 · 485 citations

Life Sciences, Pharmacology, Pharmacotherapy +17

Efficacy of recombinant birch pollen vaccine for the treatment of birch-allergic rhinoconjunctivitis

Gabrielle Pauli, Tina H. Larsen, S. Rak et al. · Journal of Allergy and Clinical Immunology · 2008 · 317 citations

Life Sciences, Immunology, Otolaryngology +14

Early onset of action of a 5-grass-pollen 300-IR sublingual immunotherapy tablet evaluated in an allergen challenge chamber

Friedrich Horak, Petra Zieglmayer, René Zieglmayer et al. · Journal of Allergy and Clinical Immunology · 2009 · 175 citations · Full text

Life Sciences, Pharmacology, Pharmacotherapy +15

Sustained 3-year efficacy of pre- and coseasonal 5-grass-pollen sublingual immunotherapy tablets in patients with grass pollen–induced rhinoconjunctivitis

A. Didier, Margitta Worm, Friedrich Horak et al. · Journal of Allergy and Clinical Immunology · 2011 · 167 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +16

Clinical efficacy of 300IR 5-grass pollen sublingual tablet in a US study: The importance of allergen-specific serum IgE

Linda Cox, Thomas B. Casale, Anjuli Nayak et al. · Journal of Allergy and Clinical Immunology · 2012 · 133 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17